Management of Crohn’s disease in an immunosuppressed COVID-19-positive patient: safety-driven prioritisation of nutritional therapy as a bridge to restarting immunosuppression

Active inflammatory bowel disease (IBD), combined immunosuppression and corticosteroid therapy have all been identified as risk factors for a poor outcome in COVID-19 infection. The management of patients with both COVID-19 infection and active IBD is therefore complex. We present the case of a 31-y...

Descripción completa

Detalles Bibliográficos
Autores principales: Harris, Clare, Harris, Richard James, Downey, Louise, Gwiggner, Markus
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2021
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7986758/
https://www.ncbi.nlm.nih.gov/pubmed/33753379
http://dx.doi.org/10.1136/bcr-2020-239404

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7986758/
https://www.ncbi.nlm.nih.gov/pubmed/33753379
http://dx.doi.org/10.1136/bcr-2020-239404

Ejemplares similares